The Future of Diabetes Care – Artificial Intelligence, Telemedicine, and Automated Insulin Delivery

A fascinating session at the EASD 2022 conference on emerging technologies shed light on where we are with AID and telemedicine, and what leading researchers in diabetes believe is coming next in diabetes management. Healthcare is rapidly evolving, and now more than ever, robots and artificial intelligence have gone from science fiction to critical components of diabetes management. At the EASD 2022 conference in Stockholm, Sweden, researchers further explored this concept in a session titled, "A New Hope or Strange New Worlds: Submerging diabetes into emerging technologies." Dr. Moshe Phillip, head of the Institute of Endocrinology and Diabetes at Schneider Children's Medical Center of Israel, began by demonstrating how continuous glucose monitors (CGMs) represent a paradigm shift in diabetes technology. "CGM is the most important tool in the last 20 years," he said.